Home/Filings/4/0000950170-25-032761
4//SEC Filing

Arif Bilal 4

Accession 0000950170-25-032761

CIK 0000873303other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 8:00 PM ET

Size

5.1 KB

Accession

0000950170-25-032761

Insider Transaction Report

Form 4
Period: 2025-03-03
Arif Bilal
Chief Tech Ops Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-03$103.77/sh719$74,61116,796 total
Footnotes (2)
  • [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
  • [F2]Amount of Securities Beneficially Owned includes 152 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0001959750

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:00 PM ET
Size
5.1 KB